Skip to main content
SpringerLink
Log in

The Prognostic Significance of Terminal Deoxynucleotidyl Transferase (TDT) in Patients with Leukemias and Malignant Lymphomas

  • Chapter
Terminal Transferase in Immunobiology and Leukemia

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 145))

Abstract

Since the first report of elevated terminal deoxynucleotidyl transferase (TdT) activity in leukemic cells from a patient with acute lymphoblastic leukemia (ALL)1, TdT has become one of the most widely studied phenotypic markers in hematopoietic neoplasias2–8.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. R. McCaffrey, C. F. Smoler, and D. Baltimore, Terminal deoxynucleotidyl transferase in a case of childhood acute lymphoblastic leukemia, Proc. Nat. Acad. Sci. USA. 70:521 (1973).

    Article  PubMed  CAS  Google Scholar 

  2. F.J. Bollum, Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood 54:1203 (1979).

    PubMed  CAS  Google Scholar 

  3. S. M. Marks, D. Baltimore, and R. P. McCaffrey, Terminal transferase as predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia, N. Engl. J. Med. 298:812 (1978).

    Article  PubMed  CAS  Google Scholar 

  4. G. Janossy, A. V. Hoffbrand, M. F. Greaves, K. Ganeshaguru, C. Pain, K. F. Bradstock, H. G. Prentice, H. E. M. Kzy and T. A. Lister, Terminal transferase enzyme assay and immunological membrane markers in the diagnosis of leukemia: a multiparameter analysis of 300 cases, Brit. J. Hemat. 44:221 (1980).

    Article  CAS  Google Scholar 

  5. K. F. Bradstock, A. V. Hoffbrand, K. Ganeshaguru, P. Llewellin, K. Patterson, B. Wonke, A. G. Prentice, M. Bennett, G. Pizzolo, F. J. Bollum, and G. Janossy, Terminal deoxynucleotidyl transferase expression in acute non-lymphoid leukemia: an analysis by immunofluorescence, Brit. J. Hemat. 47:133 (1981).

    Article  CAS  Google Scholar 

  6. G. Janossy, R. K. Woodruff, M. J. Pippart, G. Prentice, A. V. Hoffbrand, A. Paxton, T. A. Lister, C. Bunch, and M. F. Greaves, Relation of “lymphoid” phenotype and response to chemotherapy incorporating vincristine - prednisone in the acute phase of Ph’ positive leukemia. Cancer 43:426 (1979).

    Article  PubMed  CAS  Google Scholar 

  7. R. Mertelsmann, I. Mertelsmann, B. Koziner, M. A. S. Moore, and B. D. Clarkson, Improved biochemical assay for terminal deoxynucleotidyl transferase in human blood cells: Results in 89 adult patients with lymphoid leukemias and malignant lymphomas in leukemic phase. Leuk. Res. 2:57 (1978).

    Article  Google Scholar 

  8. M. J. Modakr R. Mertelsmann, B. Koziner, R. Pahwa, M. A. S. Moore, B. D. Clarkson, and i?. A. Good, A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias, J. Can. Res. Clin. Oncol. 98:91 (1980).

    Article  Google Scholar 

  9. R. Mertelsmann, D. A. Filippa, B. Koziner, E. Grossbard, J. Beck, S. Gupta, R. A. Good, M. A. S. Moore, P. H. Lieberman, and B. D. Clarkson, Correlation of biochemical and immunological markers with conventional morphology and clinical featues in 120 patients with malignant lymphomas. Adv. Exp. Med. Biol. 114:553 (1979).

    Article  PubMed  CAS  Google Scholar 

  10. R. Mertelsmann, B. Koziner, D. A. Filippa, E. Grossbard, G. Incefy, M. A. S. Moore, and B. D. Clarkson, Clinical significance of TdT, surface markers and CFU-c in 297 patients with hematopoietic neoplasias, in: “Modern Trends in Human Leukemia III”, R. Neth, R. C. Gallo, P. H. Hof Schneider, and K. Mannweiler eds., Springer-Verlag, Berlin-Heidelberg-New York, (1979).

    Google Scholar 

  11. R. Mertelsmann, Leukaemien und maligne Lymphome. Phaenotypische und pathophysiologische Untersuchungen und ihre klinische Bedeutung, Georg Thieme Verlag, Stuttgart (1981).

    Google Scholar 

  12. R. Mertelsmann, B. Koziner, P. Ralph, D. Filippa, S. McKenzie, Z. A. Arlin, T. S. Gee, M. A. S. Moore, and B. D. Clarkson, Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase positive acute leukemia. Blood 51:1051 (1978).

    PubMed  CAS  Google Scholar 

  13. R. Mertelsmann, M. A. S. Moore, and B. D. Clarkson, Sequential marrow culture studies and terminal deoxynucleotidyl transferase activities in myelodysplastic syndromes, in: “Preleukemia”, F. Schmalzl, and K. P. Hellreigel eds., Springer Verlag, Berlin—Heidelberg-New York, (1979).

    Google Scholar 

  14. Z. A. Arlin, K. K. Jain, T. S. Gee, S. J. Kempin, R. S. K. Chaganti, and B. D. Clarkson, Improved response in terminal deoxynucleotidyl transferase (TdT) positive blastic phase of chronic myelogenous leukemia (CML) treated with an intensive regimen for acute lymphoblastic leukemia (ALL), ASCO Abstract #690, 509 (1981).

    Google Scholar 

  15. B. Koziner, D. A. Filippa, R. Mertelsmann, S. Gupta, B. Clarkson, R. A. Good, and F. P. Siegal, Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Am. J. Med. 62:556 (1977).

    Article  Google Scholar 

  16. J. M. Bennett, D. Catovsky, Af. T. Daniel, G. Flandrin, D. A. G, Galton, H. Ré Gralnick and C. Sultan, Proposals for the Classification of the acute leukaemias, Brit. J. Hemat. 33:451 (1976).

    Article  CAS  Google Scholar 

  17. R. Mertelsmann, H. T. Thaler, L. To, T. S. Gee, S. McKenzie, P. Schauer, A. Friedman, Z. Arlin, C. Cirrincione, and B. Clarkson, Morphological classification, response to therapy and survival in 263 adult patients with acute non-lymphoblastic leukemia. Blood 56;773 (1980).

    PubMed  CAS  Google Scholar 

  18. D. A. Filippa, P. H. Lieberman, R. A. Erlandson, B. Koziner, F. P. Siegal, A. Turnbull, A. Zimring, and R. A. Good, A study of malignant lymphomas using light and ultramicroscopic, cytochemical, and immunological techniques. Correlation with clinical features. Am J. Med. 64:259 (1978).

    Article  PubMed  CAS  Google Scholar 

  19. H. Riehm, H. Gadner, G. Henze, H. J. Langermann, and E. Odenwald, The Berlin childhood acute lymphoblastic leukemia therapy study. Am. J. Pediatr. Hematol. Oncol. 2:299 (1980).

    Google Scholar 

  20. B. Clarkson, P. Schauer, R. Mertelsmann, T. S. Gee, Z. Arlin, S. Kempin, M. Bowling, P. Du four, C. Cirrincione and J. Burchenal, Results of intensive treatment of acute lymphoblastic leukemia in adults, in: “Cancer: Achievements, challenges and prospects for the 1980s”, J. H. Burchenal, and H. F. Oettgen, eds., Grune & Stratton, New York, 2:317 (1981).

    Google Scholar 

  21. E. Gold, R. Mertelsmann, D. Filippa, B. Koziner, T. H. Szatrowski, P. H. Lieberman, T. S. Gee, and B. Clarkson, Prognostic significance of surface markers, TdT, clinical parameters and three histopathological classifications in diffuse lymphomas. Am. Soc. Hematol. (Abstract) (1981).

    Google Scholar 

  22. B. Koziner, R. Mertelsmann, and D. A. Filippa, Adult lymphoid neoplasias of T and null cell types, in: “Differentiation of normal and neoplastic hematopoietic cells”, B. Clarksop P. A. Marks, J. E. Till, eds., Cold Spring Harbor Conferences on Cell Proliferation, 5:843 (1978).

    Google Scholar 

  23. R. I. Fisher, S. M. Hubbard, V. T. DeVlta, C. W. Berard, R. Wesley, J. Cossman and R.C. Yound, Factors predicting long- term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma. Blood 58:45 (1981).

    PubMed  CAS  Google Scholar 

  24. M. G. Kris, R. Mertelsmann, S. Jhanwar, R, Chaganti, T. H. Szatrowski, T. 5. Gee, S. Kempin, Z. Arlin, and B. Clarkson, Prognostic significance of pretreatment marrow cytogenetic studies in acute non-lymphocytic leukemia (ANLL), Am, Soc. Hemat. (Abstract), (1981).

    Google Scholar 

  25. E. J. Freireich, M. J. Keating E. A. Gehan, K. B. McCredie, G. P. Bodey, and T. Smith, Therapy of acute myelogenous leukemia. Cancer 42:874 (1978).

    Article  PubMed  CAS  Google Scholar 

  26. P. Schauer, Z. Arlin, R. Mertelsmann, C. Cirrincione, A. Friedman, T. S. Gee, M. Bowling, S. Kempin, D. J. Straus, B. Koziner, S. Mackenzie, H. T. Thaler, P. Dufour, C. Little, C. Dellaquilla, S. Ellis and B. Clarkson, Treatment of acute lymphoblastic leukemia in adults. Results of the L-10 and L-IOM protocols, submitted for publication.

    Google Scholar 

  27. C. N. Coleman, J. R. Cohen, J. S. Burke and S. A. Rosenberg, Lymphoblastic lymphoma in adults: Results of a pilot protocol. Blood 57:679 (1981).

    PubMed  CAS  Google Scholar 

  28. A. Bernard, L. Boumsell, E. L. Reinkerz, L. M. Nadler, J. Ritz, H. Coppin, Y. Richard, F. Valensi, J. Dausset, G. Flandrin, J. Lemerle, and S. F. Schlossman, Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: Evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood 57:1105 (1981).

    PubMed  CAS  Google Scholar 

  29. M. A. S. Moore, Prediction of relapse and remission in AML by marrow culture criteria. Blood Cells 2:109 (1976).

    Google Scholar 

  30. H. E. Broxmeyer, E. Grossbard, N. Jacobsen and M. A. S. Moore, Persistence of inhibitory activity against normal bone-marrow cells during remission of acute leukemia, N. Engl. J. Med. 301:346 (1979).

    Article  PubMed  CAS  Google Scholar 

  31. R. Mertelsmann, S. Gillis, B. Koziner, and M. A. S. Moore, Abnormal T cell growth factor (Interleukin 2) response pattern in human leukemias exhibiting high terminal transferase activity, in: “Differentiation factors in cancer” M. A. S. Moore, eds., Raven Press, New York, (1981) in press.

    Google Scholar 

  32. R. Mertelsmann, S. Gillis, G. Steinmann, P. Ralph, M. Stiehm, B. Koziner, and M. A. S. Moore, T-cell growth factor (Interleukin-2) and terminal transferase in human leukemias and lymphoblastic cell lines, Blut, (1981) in press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Developmental Hematopoiesis Laboratory and Hematology/Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, N.Y., 10021, N.Y., USA

    Roland Mertelsmann

Authors
  1. Roland Mertelsmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. CNR Institute of Biochemical and Evolutionary Genetics, Pavia, Italy

    Umberto Bertazzoni (CEC Official) (CEC Official)

  2. Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA

    F. J. Bollum

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Plenum Press, New York

About this chapter

Cite this chapter

Mertelsmann, R. (1982). The Prognostic Significance of Terminal Deoxynucleotidyl Transferase (TDT) in Patients with Leukemias and Malignant Lymphomas. In: Bertazzoni, U., Bollum, F.J. (eds) Terminal Transferase in Immunobiology and Leukemia. Advances in Experimental Medicine and Biology, vol 145. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8929-3_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8929-3_23

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-8931-6

  • Online ISBN: 978-1-4684-8929-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation